Is Mitochondrial+ blend legal in Canada?

A 55 mg three-peptide vial, sold at 9 mg SS-31, 16 mg TB-500 and 30 mg MOTS-c. MOTS-c is more than half the powder and has no human trial; the SS-31 component with an actual phase 3 programme is the smallest share at 16.4%; and the third component is a repair peptide with no mitochondrial rationale at all.

This vial is the clearest case in the batch of the arithmetic changing what the product is. The split is 9 mg SS-31, 16 mg TB-500 and 30 mg MOTS-c, 55 mg of powder.

Mechanism: SS-31 binds cardiolipin in the inner mitochondrial membrane and is described as stabilising it. MOTS-c is a mitochondrially encoded peptide described as activating AMPK.

Regulatory history: Not approved. None of the three components holds a marketing authorisation and no regulator has evaluated the combination.

Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.

The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Mitochondrial+ blend at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.